Ucb Collaborates With Veeva Systems

Rocket Pharmaceuticals Announced That The U.S. Food And Drug Administration (Fda) Has Granted Regenerative Medicine Advanced Therapy (Rmat) Designation To Rp-L301, The Investigational Lentiviral-Based Gene Therapy For Pyruvate Kinase Deficiency (Pkd), A Rare Blood Disorder Characterised By Severe Anaemia And Excessive Red Blood Cell Breakdown.Results From The Rp-L301 Programme Demonstrated Robust Efficacy In Both Adult Patients For Up To 30 Months Post-Infusion Demonstrated By Normalised Haemoglobin (From Baseline Levels In The 7.0-7.5 G/Dl Range), Improved Haemolysis Parameters, Red Blood Cell Transfusion Independence And Improved Quality Of Life With Documented Improvements Via Formal Quality Of Life Assessments. Receiving Rmat Designation From The Fda For Rp-L301 Is A Major Achievement To Bring The First Potentially Curative Gene Therapy Treatment To Patients Living With Pkd Who Have High Unmet Need.Pyruvate Kinase Deficiency (Pkd) Is A Rare, Monogenic Red Blood Cell Disorder Resulting From A Mutation In The Pklr Gene Encoding For The Pyruvate Kinase Enzyme, A Key Component Of The Red Blood Cell Glycolytic Pathway. Patients With Pkd Have A High Unmet Medical Need, As Currently Available Treatments Include Splenectomy And Red Blood Cell Transfusions, Which Are Associated With Immune Defects And Chronic Iron Overload.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!